BLA
VCEL icon

Balter Liquid Alternatives’s Vericel Corp VCEL Stock Holding History

Balter Liquid Alternatives’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-30,891
Closed -$541K – 185
2019
Q1 		$541K Buy
+30,891
New +$565K 0.3% 101

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Balter Liquid Alternatives's VCEL Position: Q2 2019 in Review

Balter Liquid Alternatives sold out of Vericel Corp (VCEL) in Q2 2019, closing a stake of 30,891 shares — an estimated $541K sold.

Balter Liquid Alternatives first reported a position in VCEL in Q1 2019 and held it in 1 quarter. The position peaked at $541K in Q1 2019. 137 funds tracked by Wall St. Rank hold VCEL as of Q2 2019.

  • Balter Liquid Alternatives reported no remaining Vericel Corp position as of Q2 2019 after selling out during the quarter.
  • Balter Liquid Alternatives sold 30,891 Vericel Corp shares in Q2 2019, an estimated $541K.
  • Balter Liquid Alternatives first reported a position in Vericel Corp in Q1 2019 and held it in 1 quarter.
  • Balter Liquid Alternatives's Vericel Corp position peaked at $541K in Q1 2019.
  • 137 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2019.

Based on Balter Liquid Alternatives's 13F filing for Q2 2019, filed 31 Jul 2019.